论文部分内容阅读
高半胱氨酸血症是心血管疾病的危险因素,但降低半胱氨酸治疗是否能改善心肌梗死病人的预后目前还证据不足。在近期完成的一项多中心临床试验中,3 749名急性心肌梗死病人随机接受B族维生素降低半胱氨酸治疗或安慰剂:(1)每天0.8 mg叶酸+0.4 mg维生素B12+40 mg维生素B6;(2)0.8mg叶
Homocysteinemia is a risk factor for cardiovascular disease, but there is insufficient evidence to suggest whether cysteine therapy can improve the prognosis of patients with myocardial infarction. In a recently completed multicenter trial, 3 749 patients with AMI were randomized to receive either B cysteine or placebo: (1) 0.8 mg folic acid daily plus 0.4 mg vitamin B12 plus 40 mg vitamins B6; (2) 0.8 mg leaf